Abstract
Glaucoma is the second leading cause of blindness in the world and the main cause of irreversible blindness [1]. The incidence of glaucoma in general population is about 0.21–1.64%. It is estimated that there were about 60.5 million people with glaucoma in 2010 and will increase to 79.6 million by 2020, with primary open-angle glaucoma (POAG) being the main type [2]. Glaucoma signifies a worldwide public health issue rather than just a disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Resnikoff S, Pascolini D, Etya D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;11(82):844–51.
Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.
Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The baltimore eye survey. Arch Ophthalmol. 1991;109(8):1090–5.
Jonas JB. Role of cerebrospinal fluid pressure in the pathogenesis of glaucoma. Acta Ophthalmol. 2011;89(6):505–14.
Hulsman CA, Vingerling JR, Hofman A, et al. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol. 2007;125(6):805–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Li, Z., Liu, D., Wang, N. (2019). Correlation Among Intraocular Pressure, Intracranial Pressure, and Blood Pressure. In: Wang, N. (eds) Intraocular and Intracranial Pressure Gradient in Glaucoma. Advances in Visual Science and Eye Diseases, vol 1. Springer, Singapore. https://doi.org/10.1007/978-981-13-2137-5_36
Download citation
DOI: https://doi.org/10.1007/978-981-13-2137-5_36
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2136-8
Online ISBN: 978-981-13-2137-5
eBook Packages: MedicineMedicine (R0)